We are live on ! Find out more
CM

Crestline Management Portfolio holdings

AUM $46.3M
1-Year Est. Return 48.82%
This Fund
S&P 500
This Quarter Est. Return
+19.23%
1 Year Est. Return
+48.82%
3 Year Est. Return
+52.52%
5 Year Est. Return
+37.91%
10 Year Est. Return
+316.44%
AUM
$1.08B
AUM Growth
+$128M
Cap. Flow
-$13.4M
Cap. Flow %
-1.24%
Top 10 Hldgs %
65.89%
Holding
283
New
55
Increased
41
Reduced
42
Closed
144

Top Buys

Rank Stock Value
1
AQST icon
Aquestive Therapeutics
AQST
+$190M
2
PGRE
Paramount Group
PGRE
+$8.09M
3
O icon
Realty Income
O
+$7.08M
4
HST icon
Host Hotels & Resorts
HST
+$6.74M
5
AVGO icon
Broadcom
AVGO
+$6.66M

Top Sells

Rank Stock Value
1
ATH
Athene Holding Ltd. Class A Common Shares
ATH
+$11.1M
2
AMG icon
Affiliated Managers Group
AMG
+$11M
3
INFO
IHS Markit Ltd. Common Shares
INFO
+$10.3M
4
JEF icon
Jefferies Financial Group
JEF
+$9.88M
5
SEIC icon
SEI Investments
SEIC
+$9.45M

Sector Composition

Rank Sector Weight
1 Healthcare 60.27%
2 Real Estate 10.75%
3 Technology 10.08%
4 Industrials 8.07%
5 Consumer Discretionary 3.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CCXI
251
DELISTED
ChemoCentryx, Inc.
CCXI
– –
-19,514
Closed -$257K
GCP
252
DELISTED
GCP Applied Technologies Inc.
GCP
– –
-59,716
Closed -$1.73M
SAIL
253
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
– –
-71,772
Closed -$1.76M
CALA
254
DELISTED
Calithera Biosciences, Inc
CALA
– –
-4,347
Closed -$435K
CERN
255
DELISTED
Cerner Corp
CERN
– –
-25,000
Closed -$1.5M
HSTO
256
DELISTED
Histogen Inc. Common Stock
HSTO
– –
-1,264
Closed -$1.08M
INFO
257
DELISTED
IHS Markit Ltd. Common Shares
INFO
– –
-199,340
Closed -$10.3M
ATH
258
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
– –
-253,193
Closed -$11.1M
ADMS
259
DELISTED
Adamas Pharmaceuticals
ADMS
– –
-82,912
Closed -$2.14M
KDMN
260
DELISTED
Kadmon Holdings, Inc.
KDMN
– –
-393,476
Closed -$1.57M
ALXN
261
DELISTED
Alexion Pharmaceuticals
ALXN
– –
-41,179
Closed -$5.11M
GWPH
262
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
– –
-18,452
Closed -$2.58M
AMAG
263
DELISTED
AMAG Pharmaceuticals
AMAG
– –
-41,727
Closed -$814K
AIMT
264
DELISTED
Aimmune Therapeutics
AIMT
– –
-109,496
Closed -$2.94M
AMTD
265
DELISTED
TD Ameritrade Holding Corp
AMTD
– –
-136,507
Closed -$7.48M
ETFC
266
DELISTED
E*Trade Financial Corporation
ETFC
– –
-15,113
Closed -$924K
PTLA
267
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
– –
-13,564
Closed -$512K
TECD
268
DELISTED
Tech Data Corp
TECD
– –
-35,000
Closed -$2.87M
AGN
269
DELISTED
Allergan plc
AGN
– –
-32,635
Closed -$5.44M
FOMX
270
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
– –
-217,670
Closed -$1.09M
DERM
271
DELISTED
Dermira, Inc.
DERM
– –
-106,593
Closed -$981K
BID
272
DELISTED
Sotheby's
BID
– –
-48,041
Closed -$2.61M
CRAY
273
DELISTED
Cray, Inc.
CRAY
– –
-108,430
Closed -$2.67M
WP
274
DELISTED
Worldpay, Inc.
WP
– –
-28,500
Closed -$2.33M
BEL
275
DELISTED
Belmond Ltd.
BEL
– –
-93,352
Closed -$1.04M
8 9 10
11
12

Similar funds

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
RRC
Range Rock Capital Wellesley, Massachusetts $46.7M AUM
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
NPCM
New Paradigm Capital Management Great Falls, Virginia $46.8M AUM
FCM
Firsthand Capital Management San Jose, California $46.9M AUM 114.33% 1-Year Est. Return
EGI
EAM Global Investors Solana Beach, California $47.1M AUM 320.45% 1-Year Est. Return
IPHI
Inflection Point Holdings II New York $47.3M AUM
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Crestline Management's Q3 2018 Portfolio in Review

As of Q3 2018, Crestline Management held 283 positions worth $1.08B, up 13% from $952M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Crestline Management's Q3 2018 filing shows 55 new, 41 increased, 42 reduced and 144 closed positions. Its largest new stake was Aquestive Therapeutics: 11,503,294 shares worth $201M. The largest sale was Athene Holding Ltd. Class A Common Shares, an estimated $11.1M.

By sector, the portfolio is most concentrated in Healthcare at 60% of assets, up from 43% a quarter earlier, followed by Real Estate and Technology.

  • Crestline Management's largest Q3 2018 buy was Aquestive Therapeutics: 11,503,294 shares worth $201M.
  • Crestline Management added most to Red Hat Inc in Q3 2018, an estimated $6.11M increase.
  • Crestline Management's biggest Q3 2018 reduction was Norwegian Cruise Line, cutting an estimated $4.27M.
  • Crestline Management fully exited Athene Holding Ltd. Class A Common Shares in Q3 2018, selling an estimated $11.1M.
  • Crestline Management's ten largest holdings make up 66% of its $1.08B portfolio in Q3 2018.
  • Crestline Management opened 55 new positions and closed 144 in Q3 2018.
  • Crestline Management's portfolio value rose 13% quarter-over-quarter to $1.08B.

Based on Crestline Management's 13F filing for Q3 2018, filed 14 Nov 2018.